Health Catalyst, Inc. (HCAT) director receives grant of 80,691 RSUs

Rhea-AI Filing Summary

Nelson Steven H reported acquisition or exercise transactions in this Form 4 filing.

Health Catalyst, Inc. director Steven H. Nelson received an equity compensation award of 80,691 restricted stock units (RSUs) under the company’s 2019 Stock Option and Incentive Plan. Each RSU represents one share of common stock and was reported at a transaction price of $0.0000 per share.

The RSUs will fully vest on the earlier of the one‑year anniversary of the grant date or the next Annual Meeting of the Issuer's Stockholders. Following this award, Nelson directly holds 235,499 shares of Health Catalyst common stock.

Insider Trade Summary

Net Buyer: 80,691 shares

Net Buy 1 txn

Insider Nelson Steven H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	80,691	$0.00	$0.00

Holdings After Transaction: Common Stock — 235,499 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Key Figures

RSUs granted: 80,691 RSUs Transaction price: $0.0000 per share Shares held after award: 235,499 shares +1 more

4 metrics

RSUs granted 80,691 RSUs Restricted stock units awarded to director Steven H. Nelson on 2026-07-16

Transaction price $0.0000 per share Reported transaction price for the RSU equity award

Shares held after award 235,499 shares Total direct holdings of Health Catalyst common stock by Steven H. Nelson following the transaction

RSU vesting horizon one year RSUs fully vest on the earlier of one year from grant or the next Annual Meeting of Stockholders

Key Terms

restricted stock units (RSUs), 2019 Stock Option and Incentive Plan, Annual Meeting of the Issuer's Stockholders

3 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs) granted pursuant to the 2019 Plan."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the 2019 Plan)."

Annual Meeting of the Issuer's Stockholders regulatory

"RSUs will fully vest on the earlier of the one-year anniversary or the date of the next Annual Meeting of the Issuer's Stockholders."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/20/2026 - 05:19 PM Accepted by SEC EDGAR 07/20/2026 - 05:19 PM Learn about SEC filing dates

FAQ

What insider transaction did Health Catalyst (HCAT) report for Steven H. Nelson?

Health Catalyst reported that director Steven H. Nelson received 80,691 restricted stock units (RSUs) as an equity award. Each RSU corresponds to one share of common stock, granted under the company’s 2019 Stock Option and Incentive Plan as part of director compensation.

How many Health Catalyst (HCAT) shares does Steven H. Nelson hold after this Form 4 transaction?

After the RSU award, Steven H. Nelson directly holds 235,499 shares of Health Catalyst common stock. This total reflects his updated ownership position once the 80,691 RSUs granted in the reported transaction are included in his direct holdings.

What are the vesting terms of Steven H. Nelson’s new RSUs at Health Catalyst (HCAT)?

The 80,691 RSUs granted to Steven H. Nelson vest in full on the earlier of the one‑year anniversary of the grant date or the date of Health Catalyst’s next Annual Meeting of Stockholders. Vesting remains subject to the terms of the 2019 Stock Option and Incentive Plan.

What was the reported transaction price for the Health Catalyst (HCAT) RSU grant to Steven H. Nelson?

The RSU award to Steven H. Nelson was reported at a transaction price of $0.0000 per share. This zero-dollar per-share figure is typical for equity compensation grants, reflecting that the award is not a market purchase but part of director compensation.

Under which plan were Steven H. Nelson’s RSUs granted at Health Catalyst (HCAT)?

The 80,691 restricted stock units awarded to Steven H. Nelson were granted under Health Catalyst’s 2019 Stock Option and Incentive Plan. This plan governs the terms, vesting conditions, and other requirements applicable to the RSU equity compensation grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nelson Steven H

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		80,691(1)	A	$0.00	235,499	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)